Mon, 02 Aug 2021

Hand-foot-syndrome_palmar-plantar-erythrodysesthesia-syndrome-Market

DelveInsight's "Hand-Foot Syndrome/ Palmar-Plantar Erythrodysesthesia Syndrome Market Insights" report delivers an in-depth understanding of the Hand-Foot Syndrome/ Palmar-Plantar Erythrodysesthesia Syndrome, historical & forecasted epidemiology, as well as the Hand-Foot Syndrome/ Palmar-Plantar Erythrodysesthesia Syndrome market trends in the 7MM (the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan) for the study period 2018-30.

DelveInsight's Hand-Foot Syndrome/ Palmar-Plantar Erythrodysesthesia Syndrome Market report offers an overview of pathophysiology, various diagnostic approaches, and treatment algorithm, including detailed chapters for marketed products and emerging therapies.

Some of the key highlights from the Hand-Foot Syndrome/ Palmar-Plantar Erythrodysesthesia Syndrome Market Insights.

  • Most patients had their first (92.9%) or most severe (67.9%) episode of Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome within the first 2 cycles of treatment.
  • Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome is common in patients treated with capecitabine and usually starts within the first 2 cycles of therapy.
  • It can increase the incidence of and-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome to almost 90% for all grade reactions and 24% for severe grade 3 reactions.
  • Major players such as Processa Pharmaceuticals, ONQuality Pharmaceuticals, and many others are involved in developing therapies for the treatment and management of Hand-Foot Syndrome/ Palmar-Plantar Erythrodysesthesia Syndrome Market.
  • Key Hand-Foot Syndrome/ Palmar-Plantar Erythrodysesthesia Syndrome pipeline therapies include PCS6422, OQL033, and many others.

Request for sample for deep insights into Hand-Foot Syndrome/ Palmar-Plantar Erythrodysesthesia Syndrome Market Report

Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Overview

Palmar-plantar erythrodysesthesia (PPE), also called a hand-foot syndrome, is a relatively common dermatologic toxic reaction associated with cytotoxic chemotherapy that can limit the use of such drugs.

Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Epidemiology Segmentation in the 7MM for the Study period 2020-2030

  • Total Incident cases
  • Diagnosed cases
  • Grade-specific incident cases
  • Treatable cases

Visit here for more information @ Hand-Foot Syndrome/ Palmar-Plantar Erythrodysesthesia Syndrome Market Insights

Hand-Foot Syndrome/ Palmar-Plantar Erythrodysesthesia Syndrome Market

The Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the complication, incremental healthcare spending across the world, and also expects the launch of emerging therapies during the forecast period of 2020–2030.

Hand-Foot Syndrome/ Palmar-Plantar Erythrodysesthesia Key Players

  • Processa Pharmaceuticals
  • ONQuality Pharmaceuticals
  • And many others

Hand-Foot Syndrome/ Palmar-Plantar Erythrodysesthesia Pipeline Therapies

  • PCS6422
  • OQL033
  • and many others

Hand-Foot Syndrome/ Palmar-Plantar Erythrodysesthesia Market Report Key Strengths

  • 11 Years Forecast
  • 7MM Coverage
  • Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Epidemiology Segmentation
  • Key Cross Competition
  • Highly Analyzed Market
  • Drugs Uptake

Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Key Questions Answered in the report

  • What was the Hand Foot Syndrome/ Palmar-Plantar Erythrodysesthesia Syndrome market share (%) distribution in 2017 and how it would look like in 2030?
  • What would be the Hand Foot Syndrome/ Palmar-Plantar Erythrodysesthesia Syndrome market size as well as market size by therapies across the 7MM during the forecast period (2017-2030)?
  • What are the key findings of the market across 7MM and which country will have the largest Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome market size during the forecast period (2017-2030)?
  • At what CAGR, the Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome market is expected to grow in 7MM during the forecast period (2017-2030)?
  • What would be the Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome market outlook across the 7MM during the forecast period (2017-2030)?
  • What would be the Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome market growth till 2030, and what will be the resultant market Size in the year 2030?
  • How would the market drivers, barriers, and future opportunities affect the market dynamics and subsequent analysis of the associated trends?

You may speak to our expert here @ Hand Foot Syndrome/ Palmar-Plantar Erythrodysesthesia Syndrome Market Report

Table of content

1

Key Insights

2

Executive Summary of Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome

3

Competitive Intelligence Analysis for Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome

4

Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome: Market Overview at a Glance

5

Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome: Disease Background and Overview

6

Patient Journey

7

Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Epidemiology and Patient Population

8

Treatment Algorithm, Current Treatment, and Medical Practices

9

Unmet Needs

10

Key Endpoints of Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Treatment

11

Marketed Products

12

Emerging Therapies

13

Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome: Seven Major Market Analysis

14

Attribute analysis

15

7MM: Market Outlook

16

Access and Reimbursement Overview of Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome

17

KOL Views

18

Market Drivers

19

Market Barriers

20

Appendix

21

DelveInsight Capabilities

22

Disclaimer

23

About DelveInsight

Get to know about report @ Hand-Foot Syndrome/ Palmar-Plantar Erythrodysesthesia Syndrome Market Outlook

Related Reports

DelveInsight's Head and Neck cancer Market Insights, Epidemiology and Market Forecast - 2030 report.

DelveInsight's Prostate cancer Market Insights, Epidemiology and Market Forecast - 2030 report.

DelveInsight's Cervical Cancer Market Insights, Epidemiology and Market Forecast - 2030 report.

DelveInsight's Advanced Liver Cancer - Market Insights, Epidemiology and Market Forecast - 2030 report.

DelveInsight's Advanced Pancreatic Cancer Market Insights, Epidemiology and Market Forecast 2030 report.

DelveInsight's Advanced Recurrent Ovarian Cancer - Market Insights, Epidemiology and Market Forecast - 2030 report.

DelveInsight's Anal Cancer Market Insights, Epidemiology and Market Forecast - 2030 report

Visit our blog section

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences providing comprehensive end-to-end solutions to improve performance.

Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve

For more insights into the Pharma industry, Visit Pharma, Healthcare, and Biotech Blog

Tags: , , , , , , , , , , , , , ,

See Campaign: https://www.delveinsight.com/Contact Information:Shruti Thakur

info@delveinsight.comTags:, Menafn, IPS, Reportedtimes, Extended Distribution, Research Newswire, Englishimage

Contact Information:

Shruti Thakur

info@delveinsight.com

Sign up for Boston News

a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!